Grandomics
Beijing, CN · 3 known investors
Grandomics (希望组), founded in 2011, provides third-generation (long-read) sequencing services and big-data analysis for research institutions, clinical diagnostics, and bioinformatics. The company develops its own genome assembly and variant-analysis software and operates sequencing platforms and medical testing labs in Beijing and Wuhan, China.
Investors · 3
Frequently asked questions
- What does Grandomics do?
- Grandomics (希望组), founded in 2011, provides third-generation (long-read) sequencing services and big-data analysis for research institutions, clinical diagnostics, and bioinformatics. The company develops its own genome assembly and variant-analysis software and operates sequencing platforms and medical testing labs in Beijing and Wuhan, China.
- Who are Grandomics's investors?
- Grandomics's investors include Matrix Partners China, Vitalbridge Capital, Marathon Venture Partners.
- Where is Grandomics headquartered?
- Grandomics is headquartered in Beijing, CN.